Nehal Chopra’s Sage Therapeutics SAGE Stock Holding History

Nehal Chopra’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-50,000	Closed	-$3.98M	–	20
2017 Q2	$3.98M	Hold	50,000	–	–	1.64%	20
2017 Q1	$3.55M	Buy	+50,000	New	+$2.93M	1.7%	20

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nehal Chopra's SAGE Position: Q3 2017 in Review

Nehal Chopra sold out of Sage Therapeutics (SAGE) in Q3 2017, closing a stake of 50,000 shares — an estimated $3.98M sold.

Nehal Chopra first reported a position in SAGE in Q1 2017 and held it in 2 quarters. The position peaked at $3.98M in Q2 2017. 174 funds tracked by Wall St. Rank hold SAGE as of Q3 2017.

Nehal Chopra reported no remaining Sage Therapeutics position as of Q3 2017 after selling out during the quarter.
Nehal Chopra sold 50,000 Sage Therapeutics shares in Q3 2017, an estimated $3.98M.
Nehal Chopra first reported a position in Sage Therapeutics in Q1 2017 and held it in 2 quarters.
Nehal Chopra's Sage Therapeutics position peaked at $3.98M in Q2 2017.
174 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2017.

Based on Ratan Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.